Surgery for IDH1/2 wild-type glioma invading the corpus callosum

被引:0
|
作者
Pamela Franco
Daniel Delev
Debora Cipriani
Nicolas Neidert
Elias Kellner
Waseem Masalha
Bianca Mercas
Irina Mader
Peter Reinacher
Astrid Weyerbrock
Christian Fung
Jürgen Beck
Dieter Henrik Heiland
Oliver Schnell
机构
[1] Medical Center - University of Freiburg,Department of Neurosurgery
[2] University of Freiburg,Faculty of Medicine
[3] University of Aachen,Department of Neurosurgery
[4] Medical Centre - University of Freiburg,Department of Radiology
[5] Schoen Clinic,Specialist Centre for Radiology
[6] Medical Center- University of Freiburg,Department of Neurosurgery, Division Stereotactic and Functional Neurosurgery
来源
Acta Neurochirurgica | 2021年 / 163卷
关键词
Corpus callosum glioblastoma; Butterfly glioblastoma; Glioblastoma; Neurosurgery; IDH status; Molecular diagnosis; Extent of resection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:937 / 945
页数:8
相关论文
共 50 条
  • [1] Surgery for IDH1/2 wild-type glioma invading the corpus callosum
    Franco, Pamela
    Delev, Daniel
    Cipriani, Debora
    Neidert, Nicolas
    Kellner, Elias
    Masalha, Waseem
    Mercas, Bianca
    Mader, Irina
    Reinacher, Peter
    Weyerbrock, Astrid
    Fung, Christian
    Beck, Juergen
    Heiland, Dieter Henrik
    Schnell, Oliver
    ACTA NEUROCHIRURGICA, 2021, 163 (04) : 937 - 945
  • [2] Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
    Sun, Chao
    Xiao, Liming
    Zhao, Yuanlin
    Shi, Jiankuan
    Yuan, Yuan
    Gu, Yu
    Zhang, Feng
    Gao, Xing
    Yang, Ying
    Yang, Risheng
    Qin, Junhui
    Zhang, Jin
    Wang, Chao
    Wang, Yingmei
    Wang, Zhe
    Hu, Peizhen
    Chang, Ting
    Wang, Liang
    Wang, Gang
    Chen, Huangtao
    Li, Zhuyi
    Ye, Jing
    TRANSLATIONAL ONCOLOGY, 2020, 13 (04):
  • [3] THE KETOGENIC DIET IS INEFFECTIVE IN PRECLINICAL MODELS OF IDH1 WILD-TYPE AND IDH1 MUTANT GLIOMA
    Javier, Rodrigo
    Horbinski, Craig
    NEURO-ONCOLOGY, 2021, 23 : 208 - 208
  • [4] The Ketogenic Diet is Ineffective in Preclinical Models of IDH1 Wild-type and IDH1 Mutant Glioma
    Horbinski, Craig
    Javier, Rodrigo
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 563 - 563
  • [5] Wild-type IDH1: A molecular target in IDH1 mutant cancers
    Wickenden, Julie A.
    Russell, Paul
    Smith, Amy
    Henley, Tom
    Elliott, Jane
    Gitterman, Dan
    Stockdale, Mark
    Schofield, Christine
    Torrance, Chris
    Moore, Jonathan D.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] WILD-TYPE IDH1 INHIBITS FERROPTOSIS IN GLIOBLASTOMA
    Dunterman, Madeline
    Korimerla, Navyateja
    Murnan, Kevin
    Tommasini-Ghelfi, Serena
    Wahl, Daniel
    Stegh, Alexander
    NEURO-ONCOLOGY, 2024, 26
  • [7] Wild-type and mutated IDH1/2 enzymes and therapy responses
    Remco J. Molenaar
    Jaroslaw P. Maciejewski
    Johanna W. Wilmink
    Cornelis J. F. van Noorden
    Oncogene, 2018, 37 : 1949 - 1960
  • [8] Wild-type and mutated IDH1/2 enzymes and therapy responses
    Molenaar, Remco J.
    Maciejewski, Jaroslaw P.
    Wilmink, Johanna W.
    van Noorden, Cornelis J. F.
    ONCOGENE, 2018, 37 (15) : 1949 - 1960
  • [9] Comparison of Transcriptomic Analysis between IDH1 Mutant and Wild-type of Lower Grade Glioma
    Lee, MinWook
    Jin, Hoeyoung
    Kim, Suwan
    Ji, SeonYeong
    Song, SeokJung
    Koh, DooHyun
    Choi, JoungWan
    Park, JeongMan
    Lee, YunGyeon
    Jo, GaeHoon
    Kim, JongIl
    Sim, JeongMin
    Ahn, JuWon
    Park, YoungJoon
    Kwack, KyuBum
    FASEB JOURNAL, 2020, 34
  • [10] Correction: Wild-type and mutated IDH1/2 enzymes and therapy responses
    Remco J. Molenaar
    Jaroslaw P. Maciejewski
    Johanna W. Wilmink
    Cornelis J. F. van Noorden
    Oncogene, 2018, 37 : 5810 - 5810